Publication | Open Access
Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent
35
Citations
23
References
2022
Year
ClinicalTrials.gov Identifier: NCT02969837.
| Year | Citations | |
|---|---|---|
Page 1
Page 1